Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 76 -2 (-2.56%) Jul 3
At Loss
P/B:
13.26
Market Cap:
€ 6.61B ($ 7.56B)
Enterprise V:
€ 6.09B ($ 6.97B)
Volume:
100.00
Avg Vol (2M):
66.00
Trade In:

Spyre Therapeutics Inc Operating Data

Spyre Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Spyre Therapeutics Inc (FRA:3920) Operating Data Charts